The Conversation (0)
Patient Home Monitoring and Theralase Technologies are two life science companies that made the 2015 TSX Venture Top 50 list.
Wednesday brought the release of the TSX Venture Exchange’s much-anticipated TSX Venture 50 list. Put out annually, it ranks the exchange’s strongest performers across five sectors: clean technology, diversified industries, oil and gas, technology and life science and, of course, mining.
Companies were chosen using an equal weighting of four measures: market cap growth, share price appreciation, trading volume and analyst coverage. Time listed on the TSX Venture Exchange and closing share price and market cap on December 31, 2014 are other factors that were taken into account.
Here’s a brief overview of the two life science companies that made the list.
Patient Home Monitoring (TSXV:PHM)
California-based Patient Home Monitoring is focused on acquiring small, privately held companies servicing chronically ill patients hampered by diseases caused mainly by old age and obesity. The company sees that market as fragmented and believes that by buying up such firms it will be able to increase annual revenue per patient by offering multiple services to the same patient.
Thus far it’s acquired a number of businesses, including Blackbear Medical, Resource Medical Group, LogiMedix, Care Medical Partners and California Cardio Services. Most recently, Patient Home Monitoring announced plans to acquire a company in Oklahoma that offers home-based pulmonology services.
Theralase Technologies (TSXV:TLT)
Unlike many companies listed on the TSX Venture Exchange, Theralase is not a fresh face on the block. The company was founded in 1994, and is now involved in designing, developing and manufacturing “super-pulsed, cold laser technology” that can be used for a wide range of human, companion animal and equine applications. Those include healing neural muscular skeletal conditions, inflammation reduction and increased tissue regeneration.
Already in 2015 Theralase has put out a fair amount of news, announcing just this week that it’s filed for Health Canada approval of the the TLC-2000, a next-generation therapeutic laser.
Tech picks
The other eight companies on the technology and life sciences list fall under the tech umbrella. They are as follows: POET Technologies (TSXV:PTK), Snipp Interactive (TSXV:SPN), EXO U (TSXV:EXO), Photon Control (TSXV:PHO), Spectra7 Microsystems (TSXV:SEV), Engagement Labs (TSXV:EL), Imperus Technologies (TSXV:LAB) and ProntoForms (TSXV:PFM).
Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.
Related reading: